Anti-CD19 CAR T-Cell Therapy Shows Efficacy in R/R B-Cell ALL in Adults

A single infusion of anti-CD19 chimeric antigen receptor T-cell therapy brexucabtagene autoleucel (Tecartus, Kite) ...

SEPTEMBER 22, 2021